Trusted in leading ICUs, the multi-patient use Aerogen Pro.

25 times greater lung deposition with Aerogen Pro compared to a traditional
small volume nebuliser during infant ventilation.

  • 17% lung deposition versus 3% for traditional small volume nebulisers.1
  • No added flow
  • Totally silent

Patient’s Voice

San Francisco General Hospital is a very busy Level 1 Trauma center. Transitioning from pneumatic powered nebulizers to the Aerogen system has been a great move for our severely ill patients…. We are now using the Aerogen system on our HFOV patients with much success. The system is very user friendly and any chances of contaminating the medication are decreased significantly. This product is highly recommended by our institution.

Laura Martin, RRT, UCSF

Proven Clinical Evidence2

Traditional Small
Volume Nebulizer
At the Wye
Performance Characteristics

MMAD range*

1-5µm

Residual Volume

Average < 0.1mL for 3mL dose

Calculated respirable dose**

13-17%

* MMAD: Mass Median Aerosynamic Diameter (micrometers) as measured with Anderson Cascade Impactor.

** Calculated respirable dose delivered via endotrached tube.
All data on file in Aerogen.

How does it work?

Our unique palladium vibrating mesh technology, Aerogen Vibronic® is a breakthrough in aerosol drug delivery and is at the heart of all our products.

The central aperture plate is just 5mm in diameter and is perforated with 1000 precision formed holes, that vibrate at 128,000 times per second, to produce the optimum particle size for deep lung penetration.

Find out more

Aerogen Pro Configuration Options

Product features

Flexible

Delivers all medications
approved for use with
standard nebulisers to treat
infants through to adults.

Ease of Use

The Aerogen Pro can be
powered by the Aerogen Pro
Controller or the Aerogen
USB Controller.

Economical

Multiple patient use.
Autoclavable at
132C-135C (270F-275F).

Versatile

10ml medication
cup capacity.